About 2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide
2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide (PubChem CID 91838899) has the molecular formula C14H22N4O2
and a molecular weight of 278.36 g/mol. Its IUPAC name is 2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide.
Analyze 2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide?
The IUPAC name of 2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide (CID 91838899) is 2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide.
What is the SMILES notation for 2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide?
The canonical SMILES for 2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide is CCN(CC(=O)NC1CC1)Cc1noc(C2CCC2)n1.
What is the InChIKey of 2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide?
The InChIKey is YZOILUIQSXFYNW-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H22N4O2/c1-2-18(9-13(19)15-11-6-7-11)8-12-16-14(20-17-12)10-4-3-5-10/h10-11H,2-9H2,1H3,(H,15,19).
What are the key properties of 2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide?
2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide has a molecular weight of 278.36 g/mol, XLogP of 1.44, 7 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl-ethylamino]-N-cyclopropylacetamide is sourced from PubChem (CID 91838899), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).